Back to searchBackground Papers0
Result Papers0
Derived Papers0
Evaluation of [18F]MNI-777 PET as a Marker of Tau Pathology in Subjects With Tauopathies Compared to Healthy Subjects
NCT02103894
PHASE1INTERVENTIONAL
Molecular NeuroImaging
16 participants
Started 2014-02 · Completed 2016-09
Status: Completed (as of 12-23-2025)
Conditions
Alzheimer's Disease (AD)Parkinson's Disease (PD)Chronic Traumatic Encephalopathy (CTE)Progressive Supranuclear Palsy (PSP)Frontal Temporal Dementia (FTD)+2 more
Interventions
Linked Papers (from SciSciNet-V2)
Total Papers3
Background
0Result
0Derived
0Unknown
3Total Citations Per Year
Brief Summary
The goal of this study is to assess \[18F\]MNI-777 PET imaging as a tool to detect tau pathology in the brain of individuals who carry a clinical diagnosis of a tauopathy, including: Alzheimer's Disease (AD),Parkinson's disease (PD) Progressive Supranuclear Palsy (PSP), chronic traumatic encephalopathy (CTE) and Frontal Temporal Dementia (FTD) and age- and gender-matched healthy subjects.
Sort by:
Background Papers0
No background papers linked
Result Papers0
No result papers linked
Derived Papers0
No derived papers linked